Sachin Jain, MD, MBA, has been named as successor to lead CareMore Health System when President Leeba Lessin retires on April 15. Dr Jain is an editorial board member of The American Journal of Managed Care and current chief medical officer of CareMore.
Sachin Jain, MD, MBA, has been named as successor to lead CareMore Health System when President Leeba Lessin retires on April 15. Dr Jain is an editorial board member of The American Journal of Managed Care (AJMC) and current chief medical officer of CareMore. He joined the company in 2015 and his role includes operating responsibility for market performance.
CareMore is a Medicare Advantage insurance plan originating in southern California. It provides care for frail, elderly patients and has developed an integrated patient care delivery system designed to surround patients with care.
“I am honored to be selected to lead CareMore and through my leadership the company will maintain its commitment to innovation, serving the needs of consumers and being a forerunner in value-based health care delivery,” Dr Jain said in a statement.
During his tenure with CareMore, Dr Jain has focused on improving clinical operations, advancing the performance of the clinical and operating teams, and re-invigorating clinical innovation.
Dr Jain was previously chief medical information and innovation officer at Merck, Inc, a lecturer in healthcare policy at Harvard Medical School, an attending physician at the Boston VA Medical Center, special assistant to the national coordinator for health information technology, a senior advisor to CMS, and a member of the faculty at Harvard Business School.
“When I was in public service, I learned of CareMore’s reputation for excellence,” he added. “That’s a tribute to Leeba and her tireless energy and enthusiasm. On behalf of CareMore’s associates, I wish to thank Leeba for her tremendous leadership and mentorship and I look forward to building on her legacy into the future.”
Lessin will remain with the company as a consultant and an instructor for the CareMore Academy.
“I am so proud to have led CareMore during a transformative period when we expanded our model outside of California and then outside of Medicare,” Lessin said in a statement. “It’s been very gratifying to participate in creating a model that has been replicated across the country and has proven effective in improving the lives of so many. In addition, I’m grateful to have had the opportunity to work with a visionary and committed team who strive to be CareMore 100 percent of the time.”
AJMC conducted a Q&A with Dr Jain in 2015, shortly after he joined CareMore. Read the article here.
To learn more about CareMore, read the article that appeared in the June 2015 issue of The American Journal of Accountable Care.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Medicaid, Medicare Policy Changes Could Lead to More Than 25,000 Additional Deaths, Study Says
April 30th 2024Researchers also estimated that more than 700,000 Americans with diabetes could lose insurance coverage if these proposed retractions are put into place, with some new policies already in effect.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More